Correlation Between BB Biotech and Invesco MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Invesco MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Invesco MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Invesco MSCI USA, you can compare the effects of market volatilities on BB Biotech and Invesco MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Invesco MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Invesco MSCI.

Diversification Opportunities for BB Biotech and Invesco MSCI

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between BION and Invesco is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Invesco MSCI USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco MSCI USA and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Invesco MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco MSCI USA has no effect on the direction of BB Biotech i.e., BB Biotech and Invesco MSCI go up and down completely randomly.

Pair Corralation between BB Biotech and Invesco MSCI

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Invesco MSCI. In addition to that, BB Biotech is 1.7 times more volatile than Invesco MSCI USA. It trades about -0.04 of its total potential returns per unit of risk. Invesco MSCI USA is currently generating about 0.13 per unit of volatility. If you would invest  5,582  in Invesco MSCI USA on September 12, 2024 and sell it today you would earn a total of  3,599  from holding Invesco MSCI USA or generate 64.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BB Biotech AG  vs.  Invesco MSCI USA

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Invesco MSCI USA 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco MSCI USA are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Invesco MSCI may actually be approaching a critical reversion point that can send shares even higher in January 2025.

BB Biotech and Invesco MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and Invesco MSCI

The main advantage of trading using opposite BB Biotech and Invesco MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Invesco MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco MSCI will offset losses from the drop in Invesco MSCI's long position.
The idea behind BB Biotech AG and Invesco MSCI USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals